Viewing StudyNCT00126542

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00126542
Status: COMPLETED
Last Update Posted: 2014-05-14
First Post: 2005-08-02
Brief Title: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial Fallopian Tube or Primary Peritoneal Cavity Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Stage IV Ovarian Epithelial Cancer
Fallopian Tube Cancer
Primary Peritoneal Cavity Cancer
Recurrent Ovarian Epithelial Cancer
Keywords: